Skip to main content
Premium Trial:

Request an Annual Quote

From Delight to Disappointment, All in a Single Week

It must have been an emotional rollercoaster for people involved with the Personal Genome Project this week. Monday saw all the excitement of a press conference and announcement of the data release, but by today at least one blogger says he's disappointed by the output. Daniel MacArthur at Genetic Future writes that "the data released so far makes for pretty desultory reading." He acknowledges that this is a preliminary version only and says he expects quality to improve considerably. But right now, he writes:

Even making some generous assumptions about the quality of the sequence and the size of the targeted regions, the data files currently posted on the PGP website would have a per-base coverage of around 0.5 times - in other words, each base in the target regions has been sequenced less than once, on average. That's far too low to provide useful information about the patterns of variation in these regions.

 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.